Volles Warren Karl
Transaction: 07/09/2026
OTHER
Change
+14,000
Price
Not reported
Filing
07/17/2026
Type
OTHER
Biohaven Ltd.
BHVN • Biotechnology
$15.69
▼ -0.17 (-1.07%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$2.36B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 3.18High debt level · 5.36Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:10 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$15.69
Change-1.07%
Shares Out150.64M
Market Cap$2.36B
Enterprise Value$2.39B
52W Range7.48 - 18.57
Beta3.16
P/E-4.03
P/B193.38
P/FCF-4.62
EV/EBITDA-4.21
EV/FCF-4.67
Price$15.69
Change-1.07%
Shares Out150.64M
Market Cap$2.36B
Enterprise Value$2.39B
52W Range7.48 - 18.57
Beta3.16
P/E-4.03
P/B193.38
P/FCF-4.62
EV/EBITDA-4.21
EV/FCF-4.67
Earnings Yield-24.83%
FCF Yield-21.66%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq5.36
Current Ratio3.18
Quick Ratio3.18
Target$20.25
Target Upside29.06%
Target Median$20.00
Target Range11.00 - 30.00
Volume2.13M
Avg Volume2.60M
EPS Surprise-0.02
Investment DNA
How strong this company looks for long-term investors
32
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
58/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Healthy liquidity · 3.18High debt level · 5.36Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 25 analyst votes · 2026-09-05
82/100
Bullish
Bullish
17
Hold
7
Bearish
1
Price Target
2026-08-12
Low
$10.00
Mean
$13.50
Median
$13.00
High
$18.00
Insider Transactions
Recent executive and insider activity
Volles Warren Karl
Transaction: 07/09/2026
OTHER
Change
+175,000
Price
$11.52
Filing
07/17/2026
Type
OTHER
Volles Warren Karl
Transaction: 07/09/2026
OTHER
Change
0
Price
Not reported
Filing
07/17/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Volles Warren Karl | OTHER | +14,000 | Not reported | 07/09/2026 | 07/17/2026 |
| Volles Warren Karl | OTHER | +175,000 | $11.52 | 07/09/2026 | 07/17/2026 |
| Volles Warren Karl | OTHER | 0 | Not reported | 07/09/2026 | 07/17/2026 |
| GREGORY JULIA P | BUY | +68,693 | $9.61 | 04/28/2026 | 04/30/2026 |
| HUGIN ROBERT J | BUY | +68,693 | $9.61 | 04/28/2026 | 04/30/2026 |
| CHILDS JOHN W | BUY | +68,693 | $9.61 | 04/28/2026 | 04/30/2026 |
| Antonijevic Irina | BUY | +68,693 | $9.61 | 04/28/2026 | 04/30/2026 |
| Heffernan Michael Thomas | BUY | +68,693 | $9.61 | 04/28/2026 | 04/30/2026 |
| Bailey Gregory | BUY | +68,693 | $9.61 | 04/28/2026 | 04/30/2026 |
| Mehta Kishan | BUY | +68,693 | $9.61 | 04/28/2026 | 04/30/2026 |
| Mehta Kishan | SELL | -17,342 | Not reported | 03/17/2026 | 03/19/2026 |
| CHILDS JOHN W | BUY | +28,400 | $30.43 | 03/04/2025 | 03/09/2026 |
| Coric Vlad | BUY | +550,000 | $11.52 | 02/27/2026 | 03/03/2026 |
| Car Bruce | BUY | +175,000 | $11.52 | 02/27/2026 | 03/03/2026 |
| Clark George C. | BUY | +50,000 | $11.52 | 02/27/2026 | 03/03/2026 |
| Gentile Kimberly | BUY | +175,000 | $11.52 | 02/27/2026 | 03/03/2026 |
| Buten Matthew | BUY | +175,000 | $11.52 | 02/27/2026 | 03/03/2026 |
| Clark George C. | SELL | -2,500 | Not reported | 01/05/2026 | 01/07/2026 |
| Clark George C. | SELL | -1,117 | $9.93 | 01/05/2026 | 01/07/2026 |
| Car Bruce | SELL | -4,750 | Not reported | 01/05/2026 | 01/07/2026 |